Double-Blind, Controlled Phase II Study of a 5-HT6 Receptor Antagonist, SB-742457, in Alzheimers Disease
Year: 2010
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: Current Alzheimer Research
Authors: G. Maher-Edwards, M. Zvartau-Hind, A.J. Hunter, M. Gold, G. Hopton, G. Jacobs, M. Davy, P. Williams
Institution: GlaxoSmithKline (United Kingdom)
Language: English
Subfield: Cellular and Molecular Neuroscience
Field: Neuroscience
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2121476689
